Del enters OEM business with Dynarad acquisition

Del Electronics expanded its position in medical imaging fromcomponent supply to provision of OEM x-ray and mammography systemsthrough the acquisition last week of Dynarad of Deer Park, NY.

"This is a strategic move to increase our medical business.With Dynarad we now become an OEM supplier of end items,"said Leonard A. Trugman, chairman, CEO and president of Del, basedin Valhalla, NY. "It also offers us synergistic opportunities,since the technology that our Del Power Conversion division possessesintegrates well with the OEM medical imaging equipment that Dynaradmanufactures."

Dell is a public company manufacturing high-voltage power suppliesand electronic filtration devices for the defense, medical andelectronic security industries. Dell revenues for 1991 were slightlyless than $20 million, according to a company spokesperson. Termsof the sale were not announced.

Dell will continue to supply its OEM customers with componentsand does not intend to compete head-on with the large multimodalityimaging vendors, Trugman said.

"We are not competing with our customers, the people whomake CTs and MRIs," he told SCAN.

Dynarad was formerly called Porta Ray before it acquired Voltampere,a Long Island-based power supply manufacturer, and several othersmaller firms last year.

Porta Ray was a minor player in mammography equipment manufacturingbefore the realignment. About 80% of its business originates frommobile and portable x-ray systems, according to Jerry Palmese,sales and marketing manager.

Porta Ray's fortunes rose in 1990 with a $7 million contractfor 700 field-deployable, mobile x-ray systems for the DefenseDepartment. The systems were delivered in an 18-month period endingin 1991.

Dynarad has 80 to 100 dealers in the U.S. It also sells productsthrough 30 to 40 dealers outside the country, Palmese said. Dynaraddesigned and manufactures the Nova mammography system introducedin September and marketed by Mantas of Danbury, CT.

Del plans to continue Dynarad's operations as a separate subsidiaryand to continue dealer relationships, Trugman said.

Potential Dynarad liabilities from technology-related litigationbetween the company and a former supplier, AR Custom Medical Products,will not be carried over to Del.

"We are indemnified (by Dynarad shareholders) for allof that," Trugman said. "Del has not assumed any ofthose previous obligations."